Shenzhen Weipusituo Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Weipusituo Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include STARISETME. The owner is based in Shenzhen.

101,No. 4, Lane 6, Weizhibu, Sanxi

Community,Kuiyong Street,Dapeng New Dist

Shenzhen 518100 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Shenzhen Weipusituo Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Shenzhen Weipusituo Technology Co., Ltd. have?

Shenzhen Weipusituo Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.

What trademark classes does Shenzhen Weipusituo Technology Co., Ltd. file in?

Shenzhen Weipusituo Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Shenzhen Weipusituo Technology Co., Ltd.'s most well-known trademarks?

Shenzhen Weipusituo Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as STARISETME. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Weipusituo Technology Co., Ltd.'s trademark registration success rate?

Shenzhen Weipusituo Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.